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1.  Introduction
Common multifactorial diseases are caused by genetic and/or
environmental perturbations. Moreover, disease associated
modiﬁer genes are involved which inﬂuence the individual
severity of the disease. For example, familial hypertrophic car-
diomyopathy (FHC) is caused by a mutation in a gene encoding
the sarcomeric -myosin binding protein [1]. In order to inves-
tigate the modiﬁer effect, 26 patients, all carriers of the same
mutation in the sarcomeric gene MyBP-C, were investigated
with regard to particular polymorphisms [2,3]. In spite of the
presence of the same mutation, the severity of the disease
differed among the 26 family members considerably, and this
was found to be due to distinct polymorphisms, apparently
acting as disease modiﬁers.
Recent developments in DNA analysis have led to compre-
hensive genome-wide association studies (GWAS) aimed at
detecting genes/single nucleotide polymorphisms (SNPs) that
modify the expression of a disease caused by genetic or envi-
ronmental factors. In these studies a general observation is
that many  SNPs associated with a disease can be detected,
but the vast majority of effect sizes contributing to the disease
phenotype are small [4]. For example, 47 distinct genetic vari-
ants associated with blood pressure and hypertension were
found to explain collectively only a few percent of the heri-
tability of blood pressure [5]. It has been concluded that the
complete genetic architecture of blood pressure involves pos-
sibly hundreds of genetic variants [6], but that current GWAS
results have identiﬁed only a subset of this architecture [5].
Chromosomal substitution strains (consomic strains, CS)
of the rat have been used as an animal model to screen the
chromosomes separately for disease modiﬁer loci acting as
quantitative trait loci (QTL). Two strains (BN and SS) of the rat
differing in sensitivity against hypertension have been studied
in this way [7–9]. The different chromosomes were screened
for QTLs that show association with high blood pressure.
QTLs related to blood pressure were identiﬁed, but surpris-
ingly on almost every chromosome [8]. The results suggested
that global responses to an initial stimulus of blood ﬂow, such
as salt intake, change the expression of genes throughout the
genome [10].
The results considered show that the phenotypic expres-
sion of a disease in response to a genetic variant or external
stimulus involves many  genes, but with different conse-
quences for each individual due to the polymorphisms [4].
This suggests behind the action of a particular disease gene
a global acting disease modiﬁer effect [11]. The global modi-
ﬁer would result from the cellular proteomic network and the
connected regulatory system. The efﬁciency of the functional
network in compensating the deleterious effect of the stim-
ulus would depend on the number, type and composition of
the interacting individual variants that form the genetic back-
ground of each individual.
It is a particular feature of the genetic system, that the
genome of each individual is composed of two sets of alleles,
that from the mother and that from the father, which become
combined under heterozygote conditions arbitrarily. Recently
the genome of one person was analyzed by next generation
sequencing and the maternal genome was compared with s 7 ( 2 0 1 5 ) 27–42
the paternal genome with respect to polymorphisms [12].
The two genomes differed by about 11,000 SNPs resulting in
non-synonymous amino acid exchanges in coding genes. In
addition, 178,616 SNPs were found in non-coding regions up
to 10 kb upstream of genes and 6599 in transcription factor
binding sites. The arbitrary combination of the alleles of so
many  genes in an individual may alter fundamental charac-
teristics of biological systems such as the robustness against
perturbations. This was deﬁned as a property that allows a
system to maintain its function even under internal (genetic)
or external (environment) perturbations [13,14]. In a cell the
proteomic network of interaction and expression is highly
coordinated and tightly controlled [15]. Therefore, this sys-
tem must be maintained by adapting the effect of the different
polymorphisms (and other mutations) of each individual [16].
This is a prerequisite for normal development and differenti-
ation of cells and tissues. But adapting the polymorphisms to
the proteomic system, i.e. to the network of proteins including
expression, regulation, interaction and distribution of pro-
teins, may lead to conditions not necessarily “perfect” [17] in
each case. In consequence, the proteomic system may differ
between individuals in robustness against perturbations [18].
Robustness against perturbations and its limitation has been
studied in various molecular biological systems [13,14,19–21].
Moreover, mathematical models have been proposed to deﬁne
robustness [14,16,17,21].
The aim of our investigation was to deﬁne in the proteome-
wide expression of proteins a criterion that may indicate the
capacity of an individual proteome to react robustly against
perturbations. As an animal model CSs of the mouse were
used, and the proteome of the heart was investigated by
large-gel 2-dimensional electrophoresis (2-DE) [22] and mass
spectrometry (MS). The consomic mouse model used con-
sists of 20 C57BL/6J (B6) strains, each strain differing from
each other by one chromosome (the two homozygotes) that
has been replaced by the corresponding chromosome from
another strain, the PWD/Ph (PWD) mouse strain [23]. There-
fore, the large number of polymorphisms which exist between
B6 and PWD  was reduced in each strain to the polymorphisms
(alleles) of one single chromosome, the PWD-Chr. This allows
us to test the extent of the trans-effect of the different sets
of variants encoded by the PWD-Chr of each CS on the vari-
ability of the B6 proteome (Fig. 1). According to our hypothesis
high variability in a CS (compared to B6 to detect the effect
of the PWD-Chr) may reﬂect high elasticity of the proteomic
network, i.e. high buffer capacity of proteins in up- and down-
regulation and high ﬂexibility in using alternative pathways in
protein–protein interaction. High variability might be an indi-
cation of high robustness of the proteomic network of this
CS against perturbations. In another CS, however, the par-
ticular composition of the trans-acting polymorphisms may
conﬁne the robustness of the proteome. The frequency of
trans-variant proteins of a CS induced by the cis-variant pro-
teins (the polymorphic proteins of the consomic chromosome
PWD) by protein-protein interaction was taken as a parameter
to compare the robustness of the proteomic network between
the CSs. If the trans-effect induced in the proteomic network
by the cis-variant genes/proteins is high, this would indicate
a high potential of this CS to establish homeostasis in the pro-
teomic network even in case of perturbation (high robustness).
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wig. 1 – Schematic presentation of cis- and trans-acting prote
nder converse conditions homeostasis may be only “partial”
17].
We  investigated the heart proteome of ten CSs in males and
n females. Three CSs found to differ particularly in the fre-
uency of trans-variant proteins in the heart proteome were
ested in their response to induced cardiac pressure overload.
urthermore, we  investigated the frequency of variant pro-
eins in the F1(B6xPWD) generation, the situation in that all
he 20 chromosomes from the mother (B6) come together with
ll the 20 chromosomes from the father (PWD). In parallel,
he variation in RNA expression was analyzed in 7 CSs and
ompared with the variation of proteins.
.  Experimental  procedures
.1.  Experimental  animals
onsomic strains (CSs) (chromosome substitution strains) of
he mouse based on the inbred C57BL/6J (B6) mouse carrying
 single chromosome from the mouse of the PWD/Ph inbred
train were used, and included CSs with ChrPWD No 1, 5, 9,
2, 14, 15, 16, 17, 19, or Y; males and females (Acad. Science,
nst. Molec. Genet., Prague; available from the Jackson Lab.,
SA). B6 mice were used for comparison. Each experiment
as  repeated six times with six single animals. At 9 weeks then a consomic mouse strain (CS2) versus strain C57BL/6 [18].
animals were sacriﬁced by cervical dislocation, the heart was
rapidly removed, cut, rinsed with physiological saline solu-
tion, and then ﬂash-frozen in liquid nitrogen and stored at
−80 ◦C until use. All animal procedures were performed in
accordance with the guidelines of the Charité Medical Uni-
versity Berlin, were approved by the Landesamt für Gesundheit
und Soziales (LaGeSo, Berlin, Germany) for the use of laboratory
animals (G0206/09), and followed the “Principles of Laboratory
Animal Care” [24], as well as the current version of the German
Law on the Protection of Animals.
2.2.  Transversal  aortic  constriction  (TAC)
The mice, 9 weeks of age, were anesthetized with ketamine
hydrochloride (80 mg/ml)/xylazine hydrochloride (12 mg/ml)
solution administered by intraperitoneal injection at a dose
of 1 mg/kg. Animals were placed in the supine position under
a dissecting stereoscope. Brieﬂy, after induction of anesthesia,
the mice were intubated and artiﬁcially ventilated (respirator:
Hugo Basile model 7025; FMI). After sternotomy, the aorta and
the carotid arteries were exposed, and the transverse aorta
was ligated by tying a 6-0 silk suture (FST) against a 26-gauge
needle. The needle was then removed, leaving a narrowing
of 0.4 mm in diameter. Sham animals underwent an identical
surgical procedure without placement of the suture. Animals
recovered from anesthesia under warming conditions and
o m i c30  e u  p a o p e n p r o t e 
normal ventilation. Mice were killed 63 days after TAC or sham
surgery.
2.3.  Echocardiography
Two-dimensional short- and long-axis views of the left
ventricle (LV) were obtained by transthoracic echocardiog-
raphy with the Vevo 770 Imaging System (Visual Sonics)
as described by Barrick et al. [25]. M-mode tracings were
recorded and used to determine intraventricular septum (IVS),
LV end-diastolic diameter (LVID), and posterior wall thickness
(LVPW) over three cardiac cycles in systole and diastole. 2×
LVPWd = thickness/LVIDd was calculated and is an index for
concentric myocardial hypertrophy. LV ejection fraction (EF)
was evaluated with the formula %EF = (LVVold − LVVols) × 100.
Echocardiography was performed after 2, 3, 4, 6, and 9
weeks in all operated mice after TAC or sham surgery. Detailed
protocols are described in the supplemental data for this
article available online at the American Journal of Physiology –
Regulatory, Integrative and Comparative Physiology website.
2.4.  Histology
As the most relevant parameter for cardiac remodeling we
measured in selected consomic strains the total content of
ﬁbrosis in the heart. Parafﬁn-embedded tissues, from the ani-
mals killed at 9 weeks after TAC or sham surgery, were cut in
5-m sections. Picrosirius Red (SR) staining was used for ﬁbro-
sis calculation. The ﬁbrosis score was calculated as following:
(ﬁbrotic area/total picture area) × 100. Stained sections were
quantiﬁed using AxioVision Rel.4.6 (Zeiss) and ImageJ 1.38 x
software.
2.5.  Extraction  of  total  heart  proteins
Total protein extracts were prepared from the entire heart.
The extraction procedure has been published previously and
validated [26,27]. 120 mg  frozen tissue, 1.6 parts (v/w) of
buffer P (50 mM TRIZMA® Base (Sigma–Aldrich, Steinheim,
Germany), 50 mM KCl and 20% (w/v) glycerol at pH 7.5) sup-
plemented with a ﬁnal CHAPS concentration of 4% (w/v), 0.08
parts of protease inhibitor solution 1 (1 CompleteTM tablet
(Roche Applied Science, Mannheim, Germany) dissolved in
2 ml  of buffer P) and 0.02 parts of protease inhibitor solution
2 (1.4 M pepstatin A and 1 mM phenylmethylsulfonyl ﬂuo-
ride in ethanol) were grounded to ﬁne powder in a mortar
pre-cooled in liquid nitrogen. The tissue powder was trans-
ferred into a 2 ml  tube (Eppendorf, Hamburg, Germany), and
supplied with glass beads (0.034 units of glass beads per com-
bined weight of tissue, buffers and inhibitors in mg;  glass
beads, 2.5 mm ± 0.05 mm diameter, Worf Glaskugeln GmbH,
Mainz, Germany). Each sample was sonicated 12 times in an
ice-cold water bath for 20 s each, with cooling intervals of
1 min  40 s in between. The homogenate was stirred for 30 min
at 4 ◦C in the presence of 0.025 parts (v/w) of benzonase (Merck,
Darmstadt, Germany) and a ﬁnal concentration of 5 mM mag-
nesium chloride. Subsequently, solid urea and thiourea to
give a ﬁnal concentration of 6.5 and 2 M,  respectively were
added, and stirring was continued for 30 min  at room temper-
ature until urea and thiourea were completely dissolved. The s 7 ( 2 0 1 5 ) 27–42
protein extract was supplied with 70 mM dithiothreitol (Bio-
rad, Munich, Germany), 2% (v/w) of ampholyte mixture
Servalyte pH 2-4 (Serva, Heidelberg, Germany), corrected by
the amount of urea added (correction factor = sample weight
prior to addition of urea/sample weight after addition of urea),
and stored at −80 ◦C. Protein concentrations were determined
in sample aliquots without urea using Biorad DC Protein Assay
according to the protocol supplied by the manufacturer.
2.6.  Two-dimensional  gel  electrophoresis  (2-DE)
Protein samples of the heart from single mice (n = 6), 9 weeks
of age, of the different CSs were separated by 2-DE. To detect
proteins genetically variant between the CS and the parental
strain B6, we  used the high-resolution large-gel 2-dimensional
electrophoresis technique (2-DE), developed in our laboratory
and able to resolve more  than 10,000 protein spots from com-
plex protein samples [22]. Accordingly, isoelectric focusing
(IEF) was performed in capillary tubes (0.75 mm inner diam-
eter) using carrier ampholytes (pH 3–10). The gel format in
the second dimension was 40 cm (IEF) × 30 cm (SDS-PAGE). 2-
D gels were run in batches of two. Sample pairs consisting of
one CS and the control B6 were run always in parallel in both
dimensions of 2-DE, IEF and SDS-PAGE. Extracts of 30 g pro-
tein were applied to the anodic end of the IEF gel. Proteins
were visualized in the SDS-PAGE polyacrylamide gel by highly
sensitive silver staining [22]. 2-DE gels were dried and scanned
at 300 dpi and 16 bits gray scale using the Microtek Scan Maker
9800XL scanner (Evestar GmbH, Willich, Germany).
2-DE is at present the only method which allows large scale
analysis of genetic variation of proteins with the inclusion of
quantitative and structural genetic variation, as well as vari-
ation in protein isoforms and posttranslational modiﬁcations
[28].
2.7.  Quantitative  analysis  of  proteins  revealed  by  2-DE
Protein spot patterns (n = 6) were evaluated by Delta2D imaging
software version 4.0 (DECODON, Greifswald, Germany). 2-DE
spot patterns of CS and control (B6) were matched using the
Delta2D “exact” mode matching protocol. First, sample pairs
(CS/B6) were matched separately. Subsequently, all gels were
matched to create a “match link” between all 2-DE spot pat-
terns using match vectors [29]. Using “union” mode, a fusion
image  was generated, including the visible spots for each 2-
DE gel from each group (males and females, B6 and CS). Only
the fusion image  was used for spot detection. Spots were not
edited manually after spot detection. A set of 2.345 spots of
the fusion image  was transferred to all other 2-DE gel images
for each strain. This ensures that for each stage investigated
the ID for each spot on a gel is identical. Relative spot vol-
ume  intensities (fractions of 100%) were used for quantitative
protein analysis. After background subtraction, normalized
spot intensity values were copied into Excel spreadsheets for
statistical analysis. Data sets were analyzed applying a Stu-
dents t test to determine statistical signiﬁcance of alterations
(signiﬁcance threshold p < 0.05). The Kolmogorov–Smirnov Z
test provided by the statistical analysis software SPSS Statis-
tics 21 (SPSS Inc., Chicago, USA) was used to investigate
whether the data was normally distributed. Only fold changes
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xceeding 20% were considered [30]. In case of CS versus con-
rol (B6) comparisons a t test was used to compare sample
airs which run side by side during both IEF and 2D-PAGE [26].
The rate of false positive protein changes in our 2-DE pat-
erns was evaluated as described elsewhere [31]. Moreover,
ach “real” protein spot differing signiﬁcantly was analyzed
isually with the Delta2D software tool “Gel Image  Region”
evised for the evaluation of separation of protein spots and
istinction of intensities.
.8.  Protein  identiﬁcation
or protein identiﬁcation by MS, 0.4 mg  of the respective
rotein extracts were separated on 1.5 mm (inner diameter)
EF and 1.0 mm-thick SDS-PAGE Gels and stained using a
S-compatible silver staining protocol [32]. Protein spots of
nterest were excised from 2-DE gels and subjected to in-gel
ryptic digestion [32]. Trypsin was provided by Promega (Madi-
on, WI,  USA). Tryptic fragments were analyzed by nanoﬂow
igh-performance liquid chromatography (nanoHPLC; Prox-
on Easy-nLC, Odense, Denmark)/electrospray ionization
ESI)-MS and -MS/MS on a LCQ Deca XP ion trap instru-
ent (Thermo Finnigan, Waltham, MA,  USA). Nano-HPLC was
irectly coupled to ESI-MS analysis. Protein band eluates of
8 l were loaded onto a SSPE traps C18 pre-column (5 m,
20 A˚, 100 m I.D. × 20 mm;  NanoSeparations) using 0.1% (v/v)
ri-ﬂuoroacetic acid (Merck) at a ﬂow rate of 20 l/min. Pep-
ides were separated in an analytical C18 column (5 m,  120 A˚,
5 m I.D. × 10 cm). The elution gradient was created by mix-
ng 0.1% (v/v) formic acid in water (solvent A, Merck) and 0.1%
v/v) formic acid in acetonitrile (solvent B, Merck) and run at
 ﬂow rate of 200 nl/min. The gradient was started at 5% (v/v)
olvent B and increased linearly up to 50% (v/v) solvent B after
0 min. ESI-MS data acquisition was performed throughout
he LC run. Three scan events: (i) full scan, (ii) zoom scan of
ost intense ion in full scan and (iii) MS/MS scan of the most
ntense ion in full scan were applied sequentially. No MS/MS
can on single charged ions was performed. Raw data were
xtracted by TurboSEQUEST algorithm, and trypsin autolytic
ragments and known keratin peptides were subsequently ﬁl-
ered. All DTA ﬁles generated by BioWorks version 3.2 (Thermo
cientiﬁc, Waltham, MA,  USA) were merged and converted to
ASCOT generic format ﬁles (MGF).
Mass spectra were analyzed using our in-house MAS-
OT software package license version 2.2 automatically
earching the database Uniprot sprot Version 290709 (531,473
equences; 188,463,640 residues). MS/MS  ion search was per-
ormed with following set of parameters: (i) taxonomy: Mus
usculus (16,441 sequences), (ii) proteolytic enzyme: trypsin,
iii) maximum of accepted missed cleavages: 1, (iv) mass value:
onoisotopic, (v) peptide mass tolerance: 0.8 Da, (vi) fragment
ass tolerance: 0.8 Da and (vii) variable modiﬁcations: oxida-
ion of methionine and acrylamide adducts (propionamide) on
ysteine. No ﬁxed modiﬁcations were considered. Only pro-
eins with scores corresponding to p < 0.05, with at least two
ndependent peptides identiﬁed were considered. The cut off
core for individual peptides using ESI-MS identiﬁcation was
quivalent to p < 0.05 for each peptide.
Additionally matrix assisted laser desorption ionization
MALDI)-time of ﬂight (TOF) mass spectrometry MS/MS 7 ( 2 0 1 5 ) 27–42 31
(MALDI TOF/TOF) analyses were used to identify proteins,
which could not be identiﬁed by ESI-MS. 1.5 l of peptide
extract were spotted onto to Anchor Chip (Bruker, Bremen,
Germany), dried and mixed with 1.5 l of matrix solution con-
taining 0.5 mg/ml  -cyano-4-hydroxycinammic acid in 70%
(v/v) acetonitrile, 0.1% (v/v) triﬂuoroacetic acid. Protein identi-
ﬁcation was performed by MALDI TOF/TOF (Autoﬂex III) mass
spectrometer (Bruker Daltonik) in positive reﬂector ion mode.
A peptide calibration standard (Bruker Daltonik) was used for
external calibration. The MS measurement settings in ﬂex-
Control were as follows: detection range of m/z 800–3500, 400
laser shots per spot. MS  spectra were annotated and processed
in ﬂexAnalysis 3.0 (BrukerDaltonik) with SNAP algorithm, S/N
1, quality factor threshold 50, and “TopHat” baseline sub-
traction. Parent mass values from generated mass list were
analyzed in LIFT mode (ﬂexControl 3.0). The fragmentation
mode MS/MS was set as following: detector gain boost 110%,
laser power boost 130%, and analog offset 0.5% and param-
eters, precursor ion selection of 0.65%. MS/MS  spectra were
annotated and processed in ﬂexAnalysis 3.0 (BrukerDaltonik)
with SNAP algorithm, S/N 1, Quality Factor Threshold 50,
Smooth and Baseline Subtraction.
MS/MS ion search was performed in Biotools 2.2 (Bruk-
erDaltonics, Bremen, Germany) and MASCOT software version
2.2 (in house license, matrixsince, London, UK) with the
following set of parameters: (i) database: Uniprot sprot Ver-
sion 290709 (531,473 sequences; 188,463,640 residues), (ii)
taxonomy: Mus  musculus (16,441 sequences), (iii) proteolytic
enzyme: trypsin, (iv) maximum of accepted missed cleavages:
1, (v) mass value: monoisotopic, (vi) peptide mass tolerance:
70 ppm, (vii) fragment mass tolerance: 0.7 Da and (viii) variable
modiﬁcations: oxidation of methionine. No ﬁxed modiﬁca-
tions were considered.
2.9.  Label-free  quantiﬁcation  by  mass  spectrometry
For online LC–MS/MS analysis 10 l of the mouse heart total
protein extracts (approx. 133 g) was diluted with 50 mM
ammonium bicarbonate digestion buffer to a concentration of
1 g/l.  Ten micrograms  of these proteins were then reduced
with dithiothreitol (DTT) and alkylated with iodoacetamide
(IAA) prior to in solution protein digestion with trypsin. After
desalting of the peptide solution with zip-tips, peptide mix-
tures (WT  BL-6, CS12 and CS14; 5 biological replicates each)
were separated by reversed phase chromatography using the
Proxeon Easy nLC II system (Thermo Fisher Scientiﬁc) on
in-house manufactured 25-cm fritless silica microcolumns
with an inner diameter of 75 m.  Columns were packed with
ReproSil-Pur C18-AQ 3-m resin (Dr. Maisch GmbH). Separa-
tion was performed using a 10–60% ACN gradient (240 min)
with 0.1% formic acid at a ﬂow rate of 200 nl/min. Eluting
peptides were directly ionized by electrospray ionization and
transferred into the oriﬁce of a linear trap quadrupole Orbit-
rap hybrid mass spectrometer (Thermo Fisher Scientiﬁc). Mass
spectrometry was performed in the data-dependent mode
with one full scan in the Orbitrap (m/z = 300–1700; resolu-
tion = 60,000; target value = 1 × 106). The ﬁve most intense
ions with a charge state greater than 1 were selected (tar-
get value, 5000; monoisotopic precursor selection enabled)
and fragmented in the linear trap quadrupole using CID
o m i c32  e u  p a o p e n p r o t e 
(35% normalized collision energy and wideband activation
enabled). Dynamic exclusion for selected precursor ions was
60 s. Protein identiﬁcation and label free quantiﬁcation were
performed with the MaxQuant software package (version
1.2.2.5) [33]. Statistical analysis of LFQ-data was performed
with Welch’s t-test [33–35]. The correction of potentially
false positives in the LFQ-data was performed by calcula-
tions with a permutation based false discovery rate [36]. The
MS/MS  spectra were matched against International Protein
Index (IPI) mouse database (version 3.84) and against 248
frequently observed laboratory contaminants as provided by
the MaxQuant software package, and calculated using the
MaxQuant search engine Andromeda [37]. Search parameters
were as follows: Precursor mass tolerance was set to 20 ppm,
the mass tolerance for fragment ions was set to 0.5 Da, tryp-
tic speciﬁcity allowing for maximum 1 missed cleavage sites
and K/R cleavages (accounts for in-source fragmentation of
tryptic peptides followed by a proline residue), ﬁxed modi-
ﬁcation of carbamidomethylation of cysteine residues, and
variable modiﬁcation of oxidation of methionine residues.
“Requantify” and “match between runs” were enabled. The
target-decoy-based false discovery rate (FDR) for peptide and
protein identiﬁcation was set to 1% for peptides and proteins
and the minimum peptide length was set to 6 amino acids.
2.10.  Pathway  enrichment  analysis  in  the  protein  data
set
Ofﬁcial SwissProt-ID numbers (Uniprot, http://www.
uniprot.org/) were used to investigate differences in cell
function between the variant proteins of different CSs. In
order to detect enrichments of speciﬁc pathways in the dataset
of altered protein expression, a “WEB-based Gene SeT AnaL-
ysis Toolkit” (WEBGESTALT) tool supplied by the Vanderbilt
University at http://bioinfo.vanderbilt.edu/webgestalt/was
used. We  used the Enrichment analysis tool for KEGG (Kyoto
Encyclopedia of Genes and Genomes) [38]. The following
parameters were used to create the KEGG tables: 1. Reference
set: species “Mus musculus”, signiﬁcance level: p < 0.05, mini-
mum number of genes: 2. Statistical methods available were
“hypergeometric test” and “Fisher’s exact test”. For our data
the results were the same with either test.
2.11.  Proteome-network  analysis
The protein–protein interactions were analyzed for the pro-
teins variant in CS12 (group c12), variant in CS14 (c14) and
variant in both CS12 and Cs14 (c12/14), males. We used
the STRING protein association network (http://string-db.org,
version 9.1), but used only Mus  musculus proteins and interac-
tions that had an overall score of at least 700 (high conﬁdence
interactions). The complete network consists of 12,993 pro-
teins. For the resulting network we could easily calculate the
degree (number of neighbors) and clustering coefﬁcient for
each protein. We  also calculated the shortest-path distance
for all pairs of nodes. For a particular group of proteins (c12,
c14, c12/c14) we  calculated the average degree and clustering
coefﬁcient. We  also calculated the shortest-path average, by
taking each member and determining the average shortest-
path to all other members of the group. Note that proteins s 7 ( 2 0 1 5 ) 27–42
that were not reachable by any path were excluded from the
shortest-path analyses.
Random sampling: In order to measure the statisti-
cal signiﬁcance of the average degree/clustering coefﬁcient/
shortest-path, we randomly constructed a group of proteins,
with the same number of proteins and evaluated this group
using the same measure. We performed this procedure 10,000
times. The p-value for the real average is then the fraction of
randomizations that achieved a higher/lower average value.
In order to correct for the group speciﬁc degree distribu-
tion we  changed the randomization procedure, such that for
each node (with degree x) of the original group we drew a
protein from the set X. This set X consists of all proteins
that have the same degree x, or have a degree of x + 1 or
x − 1.
2.12.  RNA  analysis
Total RNA was prepared from frozen heart samples (males and
females) using the RNeasy Mini Kit (Qiagen GmbH, Hilden,
Germany) and according to manufacturer’s instructions. We
have proﬁled the heart transcriptome of the consomic mouse
strains, including two biological replicates per strain. Each
paired-end RNA-seq library was prepared from 10 g of total
RNA using a strand-speciﬁc strategy and following the proto-
col described in [39]. Sequencing was carried out on the HiSeq
2000 platform (Illumina) by running 2 × 51 cycles according to
the manufacturer instructions. Sequencing reads were aligned
to the mm9  assembly of the mouse reference genome using
BWA [40]. Gene levels were then quantiﬁed in reads per kilo-
base of exon model per million mapped reads (RPKM) [41] and
using the Ensembl v.53 (Mus musculus) annotation. Differen-
tial expression was inferred using the EdgeR package from
Bioconductor [42].
3.  Results
3.1.  Variation  of  proteins  due  to  polymorphisms
From the 20 consomic mouse strains B6-ChrPWD available we
selected ten strains arbitrarily for investigation in males and
females: CS1, 5, 9, 12, 14, 15, 16, 17, 19, Y (CS No of PWD
chromosome). Total heart protein extracts from these animals
were separated by large-gel 2-DE and the proteins revealed
by using highly sensitive silver staining [22]. The 2-DE pro-
tein patterns show about 4500 protein spots. Out of these
2345 spots, well separated and reproducible (n = 6) in posi-
tion and quantity, were evaluated in each strain by comparing
CS versus B6 (Fig. 2, Suppl. Tab. IA and IB). In males/females
364/375 variant protein spots were detected within the ten
CSs; 151/175 were identiﬁed by mass spectrometry (MS) (Suppl.
Tab. II). Protein spots variant in the F1(B6xPWD) animals
(versus B6) were also identiﬁed (Suppl. Tab. II). The number
of variant protein spots varied considerably between the ten
CS. In females between 12 (CS1), 23 (CS12), on one side and
80 (CS14) on the other side, in males between 26 (CS12) and
69 (CS14) (besides of 13 in CSY) (Tab. I). In order to conﬁrm our
results CS12 and CS14 males were taken to test the same heart
extracts investigated by 2-DE-MS by using label-free LC–MS.
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Fig. 2 – The 2-DE protein pattern of the heart of CS15 is shown. As an example, ﬁve protein spots variant between CS15 and
B6 (males) are indicated. On the right site the ﬁve spots are shown in comparison to B6.
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the proteins identiﬁed in CS12 as well as in CS14 and B6
mounted to 719. In comparison, CS12 versus B6 showed 39
ariant proteins, CS14 versus B6 revealed 119 variants (Suppl.
ab. III). Whereas by this approach a higher number of variants
ere detected than by 2-DE-MS, the frequency of variants in
S14 compared to CS12 (factor 3.05) was quite similar to that
ound by 2-DE-MS (factor 2.65). Even after correction of the
lpha error by calculating the permutation based false dis-
overy rate (FDR) (Suppl. Tab. III), the ratio of the remaining
igniﬁcant values of CS12 to CS14 (factor 2.43) are quite similar
o the relation that was observed with 2-DE-MS. Moreover, the
ow number of cis-variants (6%, see below) detected by 2-DE-
S was conﬁrmed by LC–MS showing 5% cis-variants among
he 119 variant proteins of CS14.
Supplementary tables related to this article can be found,
n the online version, at doi:10.1016/j.euprot.2015.03.002.
Remark: In our 2-DE pattern, in the high molecular range,
 very tight group of a very large number (by far more  than
ne hundred) of tiny spots occur, identiﬁed as far as possible
nd found to be Myh6 (myosin heavy chain). These spots may
epresent the myosin chain complex occurring under elec-
rophoretic conditions as tiny spots, fused in the upper part of
he gel. The myosin complex could not be reproducible identi-
ed and quantiﬁed for different CSs. But quantitative variation
ompared to B6 was found for many  spots in CS14 (males) and
o some extent for males and females of CS9 and CS17.
The frequency of variant proteins detected in each CS
howed a highly signiﬁcant agreement between males and
emales (Fig. 3) and demonstrates in this way the reproducibil-
ty of the 2-DE protein patterns. As an interesting ﬁnding,
hese variants were to a large extent trans-variant proteins
pparently resulting via the protein-protein interaction net-
ork from a small number of cis-variant proteins (6% found
n males, 9% in females out of the total number of variants),
he variant proteins which mapped to the consomic PWD-Chr.In order to compare the network effect (trans-effect) of the cis-
variant PWD  proteins between the different CSs we  used the
frequency of single nucleotide polymorphisms (SNP, Mouse
genome Informatics (MGI), http://www.informatics.jax.org/)
of the genes of the corresponding PWD-Chr as a reference
value. This was tested for coding-non-synonymous SNPs,
non-coding SNPs (locus-region, mRNA-UTR), and total SNPs
(including introns). We found that, within the ten CSs tested
the number of variant proteins (almost all trans-variants,
see above) did not correlate with the number of variant
genes/SNPs (Tab. IA males, IB females). Apparently, the differ-
ence in the frequency of trans-variant proteins in the different
CSs is a protein-network effect. As considered in the following,
“core-proteins” may play a central role in transmitting genetic
variation of protein expression.
We identiﬁed so far in our 2-DE pattern of the mouse
heart 491 proteins. We compared these proteins with the list
of proteins (1124 proteins) of the “Central Proteome” pub-
lished by Burkard et al. [43], combined with the list of proteins
(1581 proteins) of the “Eukaryotic Core Proteome” published
by Weiss et al. [44]. This resulted in a list of 2074 proteins,
called here core-proteins. The central proteome resulted from
analyzing seven different human cell types, and the eukary-
otic core proteome from ﬁve different organisms. The two
lists were combined here in terms of mouse genes/proteins.
Core proteins are responsible for the common fundamen-
tal cell functions, expressed as high-abundant proteins, and
they are highly connected in the proteomic network [43,44].
Core-proteins are known to be hub-proteins, i.e. proteins
which interact directly with many  other proteins [45] and
hold the whole network together [11]. Comparison with the
heart proteins as revealed in our 2-DE pattern showed that
49% of these were core proteins. Genes encoding core pro-
teins were found to correspond in human tissues to 6.4%
[46]. Based on the Burkard/Weiss list we calculated about 9%.
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Fig. 3 – Frequency of variant proteins in the heart proteome of consomic mouse strains (CS) in males and females. The
frequency of variant protein spots in males and females is highly correlated: r = 0.920 (Pearson correlation), p = 0.0001
(Students t test).
Apparently, core-proteins were drastically enriched in our 2-
DE protein patterns. This is certainly due to the fact that
2-DE detects preferentially high-abundant proteins. Among
the variant proteins detected in our CSs about 50% (males
48%, females 54%) were core-proteins. We  found among the
proteins in CSs that 38% (females 29%) were variant in several
strains among the ten stains investigated indicating multiply
connected proteins. Core proteins contribute most extensively
to protein-protein interaction [43] in contrast to low-abundant
tissue-speciﬁc proteins. In this context it is an interesting ﬁnd-
ing that CS14 with the high number of variant proteins showed
45% core proteins among these variants, whereas CS12 with
low variability in the proteome revealed only 26% core proteins
among the variants. In this calculation the representative
number of identiﬁed proteins obtained by label free MS/MS
analysis (Suppl. Tab. III, IV, V) was used and suggest that the
differences between CSs in the frequency of trans-variant pro-
teins reﬂect differences in the frequency of protein-protein
interaction (ﬂexibility) based on the core proteins.
Supplementary table related to this article can be found, in
the online version, at doi:10.1016/j.euprot.2015.03.002.
3.2.  F1  generation  versus  CSs
One would expect that F1(B6xPWD) animals show in the heart
protein pattern a similar number of variant protein spots as
the 20 different CSs in total, if the overlapping variants within
the 20 strains would be ignored. But our analysis revealed, sur-
prisingly, that the number of variant proteins in F1 animalswas drastically reduced. We  counted the different variant pro-
teins of the ten strains investigated and estimated from this
result the total number of variants which may result from all
20 strains (Fig. 4). We  found that up to 700–800 variant protein
spots have to be expected in a corresponding protein pattern
of F1 animals. However, only 86 variants in males and 70 in
females were detected. Under the heterozygote conditions in
F1 some variants may disappear in case of recessivity, but
additional variants would also occur due to positional variant
protein spots which generate two variants in F1. Therefore,
heterozygosity cannot explain the high discrepancy in the
number of variant proteins between the CSs and F1. Obviously,
each PWD  chromosome has a high potential to create variation
on the protein level based on polymorphisms, but in pres-
ence of all 20 chromosomes in F1 the variability of proteins
is drastically reduced.
3.3.  Males  and  females
Out of the 104 identiﬁed proteins variant in male CSs and 118
variant in female CSs only 50 were identical (and not necessar-
ily in the same strain). Moreover, there is a tendency in females
for down-regulation of proteins, in males for up-regulation;
only CS9 and CS19 showed the opposite relationship, and this
in a pronounced extent (Fig. 5). These ﬁndings suggest that the
genetic regulation of the proteomic network differs between
males and females proteome-wide. This is certainly due to
the sex-speciﬁc hormones, but also to hormone-independent
sex-speciﬁc regulation of transcription [47]. The effect of
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Fig. 4 – Total number of variant proteins (CS versus B6) of the heart in 20 consomic strains (CS). The number of variant
protein spots detected in 9 CS strains by 2-D-electrophoresis were  added from strain to strain without overlap and
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ex-speciﬁcity became more  obvious, when the protein pat-
erns from males and females were compared directly within
 CS. Males compared with females for instance in CS1
nd in CS14 showed sex-speciﬁc differences in a representa-
ive number of proteins, but in contrast to the pronounced
ifferences in the genetic variability found between these
ig. 5 – Quantitative regulation of variant proteins in the heart of
f proteins in males and females in different CSs and in the parene.
two strains (Tab. I), the number of sex-speciﬁcally variant
proteins was similar: 72 in CS1, 82 in CS14. At present
we investigate females after ovarectomy in different CSs.
The results will show to which extent genetic variation
in the proteome involves regulatory effects of hormones
[45,47].
 consomic strains (CS). Ratio of up- versus down-regulation
ntal strains.
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Fig. 6 – Heart ejection fraction of consomic mouse strains (males) CS1, CS12, and CS14 and parental strain B6 in the course
C treof 9 weeks after transversal aortic constriction (TAC). CSs TA
3.4.  mRNA  expression  in  CSs
In seven CSs (CS5, 12, 14, 15, 16, 17, 19, males)1 the mRNA
expression in the heart tissue was investigated. In total 1196
variant (versus B6) mRNAs, out of 13,198 mRNAs  evaluated,
were detected in the seven strains (Tab. II and Suppl. Tab. VI)
including 249 (26%) cis-variants and 947 trans-variants. The
distribution of the cis-variants over the CSs correlated with the
number of genes of the corresponding PWD  CS-Chr, but this
was not observed for the trans-variant mRNAs  (Tab. II). The
trans-variants varied among the seven CSs between 42 (CS17)
and 247 (CS15). No correlation was found between variant
mRNAs and variant proteins, evaluated on cis + trans variants
(p = 0.372, r = 0.401; data not shown). Since mRNA  uncovered a
much broader abundance range than the proteins under our
conditions, only a small number of variant mRNAs  overlapped
with the variant proteins. Furthermore, among the 612 differ-
ent mRNAs  detected in the seven CSs only 5% corresponded
to core-proteins according to Burkard/Weiss (see above).
Supplementary table related to this article can be found, in
the online version, at doi:10.1016/j.euprot.2015.03.002.
3.5.  Heart  phenotypes  of  consomic  mouse  strains
under  normal  conditions  and  after  induced  heart
hypertrophy
To study the consequences of proteome-wide effects of poly-
morphisms on the heart phenotype of different CSs, we
investigated in males and females morphological parame-
ters such as septum thickness (IVS), left ventricular internal
diameter (LVID), left ventricular posterior wall (LVPW), left
ventricular mass (LVM), and body weight (BW) in three
representative consomic strains, CS1, CS12, CS14, and in
1 CS1 and CS9 were no longer available from the Max-Planck
Institute.ated blue, Sham gray; *p < 0.05 TAC versus Sham.
the parental strain B6 by echocardiographic measurements
(Suppl. Tab. VII). CS1 represents the situation low variation in
proteins versus high variation in genes of the consomic PWD-
Chr and CS14 the opposite constellation, whereas CS12 also
showed low variation in proteins, but in context with relatively
low variation in genes (Tab. I). We also evaluated two  physi-
ological properties of the heart, the left ventricular ejection
fraction (EF) and the left ventricular fractional shortening (FS)
(Suppl. Tab. VII). We  found that BW and LVM were increased
in males in all 3 consomic strains in comparison with B6.
In CS1 the increase in LVM was due to ventricular dilata-
tion and in CS14 to increased LVPW thickness; in CS12 males
the LVIDd was increased but at the borderline of signiﬁcance.
Heart function measured as EF and FS was maintained in the
consomic males. In contrast, in consomic females BW was not
increased in comparison with B6. LVM/BW was decreased in
the consomic strains CS1, CS12 and CS14. This was due to
lower wall thickness in all three strains as well as to cav-
ity dilatation in CS1 and CS12. There was a trend toward
decreased function (EF, FS) in CS1 females. Thus the con-
somic strains deviated in cardiac growth parameters under
resting conditions from B6 and this was different in males and
females.
Supplementary table related to this article can be found, in
the online version, at doi:10.1016/j.euprot.2015.03.002.
In the following we used our consomic mouse model as an
approach to test the effect of the genetic background (given
by the PWD-Chr.) on the robustness of the proteomic system
against perturbations. We  tested the response of the heart to
cardiac pressure overload under the different conditions of
the proteomic network observed. The extent of trans-variant
proteins induced by the polymorphisms was taken as a param-
eter. According to our hypotheses, high variability in the
proteome may reﬂect high ﬂexibility of the protein network
to overcome restrictions in functional pathways.
We selected out of the 10 CSs investigated so far the most
contrasting strains – CS1 and CS12 with low frequency of
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Fig. 7 – Heart hypertrophy induced in consomic mouse strains (males). Heart hypertrophy was induced in consomic mouse
strains CS1, CS12, and CS14 by transversal aortic constriction (TAC). The total content of ﬁbrosis of the heart was
determined.
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Mrotein changes versus CS14 with high frequency of protein
ariation. In these three strains (males) transversal aortic con-
triction (TAC) was induced at 9 weeks of age. The control
roups were sham operated. Testing different echocardiogra-
hic parameters under TAC conditions showed an increase in
eft ventricular mass (LVM) and a decrease in ejection fraction
EF) in CS1, CS12 and in B6 but not in CS14 (Suppl. Tab. VIII,
nd Fig. 6). Parameters of systolic function decreased in CS1,
S12, and in B6, but not in CS14 (Suppl. Tab. VIII). Moreover,
nder TAC conditions the total ﬁbrosis content of the heart
as increased (CS1: p = 0.002; CS12: p = 0.001) in CS1 and CS12
ice (CS1: Sham: 4.00%; TAC: 7.26%; CS12: Sham: 2.33%; TAC:
.48%) but was in the normal range in CS14 (Sham: 3.28%, TAC:
.48%) (Fig. 7). Thus, adaptation to pressure overload was best
chieved in CS14 whereas worst conditions were found in CS1
nd CS12.
Supplementary table related to this article can be found, in
he online version, at doi:10.1016/j.euprot.2015.03.002.
.6.  Proteome-network  analysis
e  used the representative number of variant proteins identi-
ed in CS12 and CS14 by label-free LC–MS/MS to compare the
tructure of the protein network of these two strains. CS12
as the strain with the lowest number of trans-variant pro-
eins found among the 10 CSs (males) investigated whereas
n CS14 the highest variability of proteins was found (Tab. I,
ig. 3). The STRING protein association data were used to ana-
yze three groups of proteins: Proteins variant only in CS12
group c12), only in CS14 (c14) and variant in both CS12 and
S14 (c12/14). We  calculated the average clustering coefﬁ-
ient (cliquishness), the number of neighbors (degree) and
he shortest-path distance (proximity) in these groups, and
ompared the data obtained with the result obtained for ran-
omly drawn groups with the same number of proteins (see
ethods).We  found for c12, including 19 proteins (7 proteins
not found), a signiﬁcantly decreased shortest-path distance
(p = 0.022), i.e. the pairs of proteins of that group were closer in
the network than expected by chance. The degree and cluster-
ing coefﬁcient did not demonstrate a statistically signiﬁcant
difference. For c14, including 93 proteins (13 not found), we
also found a decreased shortest-path distance (p = 0.0001).
Additionally, we  found an increase in the clustering coefﬁcient
(p = 0.042) and degree (p = 0.027). The c12/14 group (12 proteins,
1 protein not found) also showed a decreased shortest-path
distance (p = 0.001), but the degree and clustering coefﬁcient
did not show any statistical difference.
Comparing the results between the three groups, the c14
group of proteins was the only one showing statistical sig-
niﬁcant deviations in all three measurements and, more
importantly, this group had by far the shortest-path distance.
We determined the group-speciﬁc degree distributions ran-
domizations (see Methods) and found that the only measure
that remains highly signiﬁcant is the shortest-path distance
of the c14 (p = 0.0073).
3.7.  Enrichment  analysis  of  functional  protein  classes
of the  protein  network
After enrichment analysis of the variant proteins with the
KEGG database, functional protein classes were found in CS14,
variant versus B6, which differed from those found in CS12,
variant versus B6. In CS14 proteins closely connected with the
variants were related in particular to the circulatory system,
such as proteins involved in cardiac muscle contraction, and
proteins of the energy metabolism: oxidative phosphoryla-
tion, citrate cycle. In contrast, in CS12 the interacting proteins
found were not related to heart contraction: complement
and coagulation cascades (immune system), ECM-receptor
interaction (environmental information processing), and reg-
ulation of actin cytoskeleton (cell mobility) (Fig. 8).
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Fig. 8 – Protein interaction network generated in the CS14 and CS12 proteome (males) by the cis-trans and trans-trans
ork variant proteins found. Protein classes dominating the netw
4.  Discussion
In our study of the heart proteome of ten consomic mouse
strains we  consider each strain as an “individual” because
each strain possesses its own set of polymorphisms con-
tributed by the consomic PWD  chromosome. Our question was
to which extent different sets of polymorphisms modify the
proteomic network of interaction toward conditions which dif-
fer in robustness against perturbations, in particular against
complex diseases such as heart hypertrophy. In other words,
could the particular set of SNPs inherent in the genome of
each CS lead to strain speciﬁc networks of protein interactions
which act as global disease modiﬁers with different capacities
in protecting against the disease?
Consomic mouse strains offer an optimal model system to
investigate the key question in this problem: to which extent
does a polymorphic protein, i.e. a cis-variant protein coded
by the PWD  chromosome of the CS, affect the proteins from
the B6 chromosomes by trans-variation. Our observation was
that only a few cis-variants occurred in each CS, but able to
alter quantitatively a several-fold greater number of B6 pro-
teins by trans-variation. However, the response of the different
CSs to the polymorphisms was of quite different extent (e.g.
CS1 – 12 variants versus CS14 – 80 variants, females) and did
not correlate with the frequency of the variant genes of the
PWD chromosomes (Table 1). Apparently, the genetic effect
of the CSs led to a proteome network effect and this to an
extent characteristic for each CS. According to our results this
may be explained on the basis of core-proteins, i.e. by the
frequency and types of core-proteins that were affected by
trans-variation in each CS. In consequence, the conditions in
the proteomic network of each strain may be quite different,are indicated.
leading to differences in the buffer capacity of proteins, in the
potential of the proteomic network for alternative pathways,
in the kind of modiﬁcation of proteins and in other condi-
tions. As a consequence, homeostasis in the proteomic system
may not necessarily be maintained in each CS and, there-
fore, proteomic conditions may result, which are restricted in
robustness against perturbations.
Robustness can be deﬁned as a property that allows a
system to maintain its function despite external or inter-
nal perturbations and has been observed from the level of
gene transcription to the level of systemic homeostasis [13].
Robustness has been explained by using the bow-tie struc-
ture as a model [13]. The bow-tie structure is represented by
a highly conserved and highly connected core cluster inter-
faced with less connected in- and out-clusters. The robustness
against input processes such as disease conditions depends
on the ﬂexibility of the core cluster, i.e. on the ability of the
core processes to offer alternative pathways or to compen-
sate over-expression or down regulation of gene products due
to mutations. The output is then the maintenance of speciﬁc
functionalities and homeostasis in the system [13]. In terms
of our investigation performed on the proteome of the mouse
heart the core cluster would be given by the core proteins,
as published by Burkard et al. [43] and Weiss et al. [44] and
detected in our protein patterns to a high extent. The “input”
in our proteome system would be the different sets of poly-
morphisms given by the different PWD  chromosomes of the
different CSs. The “output” is then given by the cis- and trans-
variant proteins which occur in each CS. The robustness of the
proteome then depends on the ﬂexibility of the core proteome.
The high abundant and highly connected core proteins have
the capacity to compensate proteome-wide variation in up-
and down-regulation and maintain in this way homeostasis in
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Table 1 – Correlation of polymorphisms and variant proteins. Frequency of variant proteins detected in the heart
proteome of the consomic strains (CS) versus B6 compared with the frequency of SNPs identiﬁed in genes of the
corresponding CS-chromosomes PWD.
CS-strains SNPs in genes of CS-chromosomesa Variant proteins
in CSs
Coding-non-synonymous
SNPs
Non-coding SNPs:
locus-region + mRNA-UTR
Total SNPs including introns
A. Males
CS 1 171 22.41% 1224 23.64% 14,554 21.61% 29 7.97%
CS 5 106 13.89% 622 12.01% 9140 13.57% 39 10.71%
CS 9 83 10.88% 612 11.82% 6796 10.09% 44 12.09%
CS12 67 8.78% 372 7.19% 5999 8.91% 26 7.14%
CS14 87 11.40% 659 12.73% 9216 13.68% 69 18.96%
CS15 60 7.86% 526 10.16% 7548 11.21% 42 11.54%
CS16 47 6.16% 349 6.74% 4359 6.47% 29 7.97%
CS17 78 10.22% 422 8.15% 5040 7.48% 44 12.09%
CS19 64 8.39% 391 7.55% 4696 6.97% 29 7.97%
CSY 0 0.00% 0  0.00% 0 0.00% 13 3.57%
Correlation
variant
proteins – SNPs
r  = 0.319 r = 0.366 r = 0.422
p = 0.369 p = 0.298 p = 0.224
B. Females
CS 1 171 22.41% 1224 23.64% 14,554 21.61% 12 3.20%
CS 5 106 13.89% 622 12.01% 9140 13.57% 40 10.67%
CS 9 83 10.88% 612 11.82% 6796 10.09% 55 14.67%
CS12 67 8.78% 372 7.19% 5999 8.91% 23 6.13%
CS14 87 11.40% 659 12.73% 9216 13.68% 80 21.33%
CS15 60 7.86% 526 10.16% 7548 11.21% 47 12.53%
CS16 47 6.16% 349 6.74% 4359 6.47% 40 10.67%
CS17 78 10.22% 422 8.15% 5040 7.48% 56 14.93%
CS19 64 8.39% 391 7.55% 4696 6.97% 22 5.87%
Correlation
variant
proteins – SNPs
r  = −0.320 r = −0.228 r = −0.191
p = 0.402 p = 0.556 p = 0.622
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ia Mouse Genomics Informatics (MGI) Database.
he proteome. However, whereas homeostasis is a stabilizing
actor necessary to keep protein expression and interaction in
alance, enough ﬂexibility in the system must be maintained
o allow the proteomic network to react against perturbation
48]. The scope of variability in the proteome above homeosta-
is would then determine the capacity of robustness inherent
n a proteome (Table 2).
Table 2 – Variant mRNAs in consomic strains. Frequency of var
mouse strains (CS) compared to the B6 strain and related to the
CS-strains Genes/Chra
CS 5 1300 19.90% 
CS12 838 12.83% 
CS14 1101 16.86% 
CS15 793 12.14% 
CS16 671 10.27% 
CS17 1102 16.87% 
CS19 727 11.13% 
Correlation variant
mRNAs – genes
a Mouse Genomics Informatics (MGI) Database.We  found in our consomic mouse model relatively low
variability in the heart proteome of CS1 and CS12, but high
variability in CS14. Treatment of CS12 and CS14 by TAC, that
induced cardiac pressure overload, showed that CS12 was
strongly affected, but in CS14 cardiac pressure was within
the normal range. In addition, an interesting observation was
the high variability of Myh6 in the myosin spot complex in
iant mRNAs in the heart transcriptome of consomic
 number of genes per CS-chromosome PWD;  males.
Variant mRNAs in CSs
Cis-variant Trans-variant
70 28.11% 132 13.94%
33 13.25% 81 8.55%
29 11.65% 190 20.06%
28 11.24% 247 26.08%
25 10.04% 109 11.51%
37 14.86% 42 4.44%
27 10.84% 146 15.42%
r  = 0.796 r = −0.259
p = 0.032 p = 0.575
o m i c
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the 2-DE protein pattern of CS14. Myh6 is a protein tightly
involved in regulation of heart contraction and function [49].
Myh6 maps on the consomic Chr 14 and may contribute to the
robustness of the CS14 heart.
According to our hypothesis the high variability of pro-
teins found in CS14 reﬂects a high ﬂexibility of the proteomic
network based on core proteins and may explain the robust-
ness of CS14 against the induced cardiac pressure overload.
We  studied this effect with tools of bioinformatics. The com-
prehensive data obtained by LC–MS/MS were analyzed. The
results showed that the variant proteins found in CS14 were
connected with many  other proteins resulting in a complex
network (compared to random networks). Interestingly, 45%
of the primarily variant proteins were core proteins, which
are known to be highly connected (hubs) with other proteins
[43]. Moreover, in CS14 to a high extent, the proteins were con-
nected by “shortest-path” distances. These characteristics of
the CS14 proteome contrast with those found for the CS12 pro-
teome (see Results) and suggest that the genetic background
(the polymorphisms introduced) in CS14 offered the condi-
tions which allow to establish homeostasis in the proteomic
network, but also ﬂexibility to maintain robustness in the sys-
tem.
When we  looked for the functional protein classes char-
acterizing the sub-nets, resulting from the interaction of the
trans-variant proteins with related proteins, a quite different
situation was found in CS14 versus CS12 (Fig. 8). In CS14 the
proteins connected were closely related to cardiac contrac-
tion. Taking this observation into account in addition to the
close connection of proteins in CS14 by “shortest-path”, that
may allow fast reaction to perturbation, another feature of
CS14 may explain the robustness of this strain against car-
diac pressure overload. However, additional consomic strains
and sub-strains (congenic strains) have to be investigated to
draw a general conclusion from these experiments.
Whereas the polymorphisms in the “genetic architecture”
(deﬁned by Stranger et al. [4]) of a genome may lead to indi-
vidual differences in the degree of robustness of the proteomic
system, mechanisms are involved to reduce genetic variation
in order to keep the system stable. According to Jarosz et al.
[19] these mechanisms include: (1) functional redundancy by
duplication of chromosome regions or single genes, (2) func-
tional redundant pathways and epistasis, and (3) the manner
in which the genome is organized into networks of interacting
proteins and functional modules. Picotti et al. [50] have shown
in a comprehensive proteome analysis of genetically differ-
ent strains of yeast that epistatic interactions between loci
affecting protein levels are a common phenomenon and may
partly explain “missing heritability” observed in traditional
association studies [51]. Our results obtained from the pro-
teome analysis of CSs and from the F1 (PWDxB6) generation
show an impressive reduction of genetic variation of proteins.
Although F1 has the polymorphisms of all the 20 PWD  chro-
mosomes (B6/PWD heterozygotes) that should result in a large
number (700–800) of variant proteins as calculated from the
ten consomic strains investigated (Fig. 4), the number of vari-
ants in F1 was found to be below 100. Epistasis deﬁned as, “the
situation in which the alleles at one gene cover up or alter
the expression of alleles at another gene” probably compen-
sates to a large extent over-expression and down regulation s 7 ( 2 0 1 5 ) 27–42
of proteins in order to keep the proteomic system in homeo-
stasis. Shao et al. [52] investigated phenotypes of blood, bone
and metabolic traits on consomic mouse strains B6-ChrA/J. The
results showed that the overall phenotypic difference between
the parental strains was much less than the sum of the phe-
notypic differences attributable to individual chromosome
substitutions. This has been explained as an effect of epista-
sis on quantitative trait loci. These results support our ﬁnding
at the proteome level and demonstrate the consequences of
the global proteomic arrangement for the phenotypic traits. It
would be interesting to ﬁnd out whether particular classes of
proteins are preferentially restricted in variation. It is unlikely
that this process acts randomly. If the expression of poly-
morphic genes is, to some extent, selectively normalized, this
would also contribute to the individualization of the genetic
architecture of each proteome.
The results from our mouse model lead to the conclusion
that protein expression and interaction in a wild population
differs proteome-wide between individuals due to the individ-
ual genetically variant proteins (polymorphisms) which alter
many  other proteins by trans-variation. However, as a conse-
quence, homeostasis may not become established perfectly
in the proteome of each individual and this may restrict the
robustness of the system against perturbations. Testing dif-
ferent conditions of the heart proteome in response to cardiac
pressure overload suggests that the proteomic network acts
as a global disease modiﬁer. High variability in the proteomic
network may indicate high buffer capacity in case of pertur-
bation.
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